Lv1
70 积分 2022-07-20 加入
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
2个月前
已完结
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer
2个月前
已完结
Progress in the development of cytokine armoured CAR T cells
2个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
3个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
3个月前
已完结
ZAP327 signaling domain–driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models
3个月前
已完结
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
3个月前
已完结
Structure of the Cd33 Receptor and Implications for the Siglec Family
3个月前
已完结
CAR-T cell therapy for treatment of acute myeloid leukemia, advances and outcomes
3个月前
已完结
CD22-Targeted Chimeric Antigen Receptor (CAR) T Cells Containing The 4-1BB Costimulatory Domain Demonstrate Enhanced Persistence and Superior Efficacy Against B-Cell Precursor Acute Lymphoblastic Leukemia (ALL) Compared To Those Containing CD28
3个月前
已关闭
皖公网安备34019202002308
